Edition:
United Kingdom

Aptevo Therapeutics Inc (APVO.OQ)

APVO.OQ on NASDAQ Stock Exchange Global Select Market

1.58USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$1.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,300
52-wk High
$6.30
52-wk Low
$1.11

Chart for

About

Aptevo Therapeutics Inc. is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company's technology is the ADAPTIR (modular protein technology) platform. The Company... (more)

Overall

Beta: --
Market Cap(Mil.): $57.83
Shares Outstanding(Mil.): 21.42
Dividend: --
Yield (%): --

Financials

  APVO.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -5.29 -- --
ROI: -122.43 8.99 14.96
ROE: -145.10 10.13 16.53

Earnings vs. Estimates